About Annexon
Annexon is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.
Leadership at Annexon
The team at the top of the org chart.
Douglas Love
President & Chief Executive Officer
82 reports
Michael Overdorf
Executive Vice President and Chief Business Officer
21 reports
Jennifer Lew
EVP & Chief Financial Officer
4 reports
Ted Yednock
EVP & Chief Innovation Officer
1 report
Dean Richard Artis
EVP And Chief Scientific Officer
14 reports
Jamie Dananberg
Chief Medical Officer
32 reports
Violet Torneros
Exec. Director, People Operations
1 report
Rick Artis
Chief Scientific Officer
Tiffany Cisneros
Sr Executive Assistant
1 report
Board
Thomas G. Wiggans
Board Member
William H. Carson
Board Member
Jung E. Choi
Board Member, Compensation Committee Chair, Science & Technology Committee
Muneer Satter
Board Member
Will Waddill
Board Member
Jeff Goldberg
Scientific Advisor
Open Jobs at Annexon (13)
- Annexon · San Francisco Bay Area · 2mo$310k – $340k
- Annexon · San Francisco Bay Area · 3mo$190k – $224k
- Annexon · San Francisco Bay Area · 3mo$400k – $428k
- Annexon · San Francisco Bay Area · 3mo$265k – $285k
- Annexon · San Francisco Bay Area · 3mo$257k – $286k
- Annexon · San Francisco Bay Area · 3mo$194k – $216k
- Annexon · San Francisco Bay Area · 3mo$300k – $375k
- Annexon · San Francisco Bay Area · 3mo$212k – $228k
- Annexon · San Francisco Bay Area · 4mo$179k – $200k
- Annexon · San Francisco Bay Area · 6mo$354k – $377k
- Annexon · San Francisco Bay Area · 6mo$195k – $217k
- Annexon · San Francisco Bay Area · 6mo$354k – $377k
- Annexon · San Francisco Bay Area · 8mo$336k – $374k